Getein Biotech, Inc (SHA:603387)
China
· Delayed Price · Currency is CNY 8.44
+0.04 (0.48%)
Mar 10, 2026, 10:25 AM CST
Getein Biotech Market Cap
Getein Biotech has a market cap or net worth of 4.26 billion as of March 9, 2026. Its market cap has increased by 0.24% in one year.
Market Cap
4.26B
Enterprise Value
3.86B
Revenue
1.04B
Ranking
n/a
PE Ratio
20.47
Stock Price
8.44
Market Cap Chart
Since July 17, 2017, Getein Biotech's market cap has increased from 4.23B to 4.26B, an increase of 0.73%. That is a compound annual growth rate of 0.08%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Medlander Medical Technology | 4.25B |
| Ningbo David Medical Device | 4.11B |
| Shanghai Kinetic Medical | 4.43B |
| Wuhan Easy Diagnosis Biomedicine | 4.06B |
| Zhejiang Orient Gene Biotech | 4.50B |
| Medprin Regenerative Medical Technologies | 4.60B |
| Hangzhou AGS MedTech | 4.69B |
| Beijing Leadman Biochemistry | 3.74B |